BayMark Health Services is a prominent North American provider of evidence-based, medication-assisted treatment (MAT) for substance use disorders, primarily focusing on opioid dependency. The company is dedicated to offering individualized and comprehensive care that integrates pharmacotherapy, clinical counseling, recovery support, and medical services. BayMark's mission is to expand its network of highly skilled teams that prioritize patients by delivering compassionate, evidence-based treatment to improve both emotional and physical health. Their vision is to ensure that every individual seeking treatment for a substance use disorder has access to expert, non-judgmental care that aids in restoring health, strengthening families, and enhancing communities. The organization operates a wide array of treatment programs across the United States and Canada, making it the largest specialty healthcare organization of its kind in North America.
Founded in 2015 through the merger of BAART Programs and MedMark Treatment Centers, BayMark Health Services brought together a combined 50 years of experience in the field of MAT. This foundation has allowed for significant growth and the diversification of its continuum of care. The company's services are delivered through various settings, including Opioid Treatment Programs (OTPs) that utilize methadone and buprenorphine, Office-Based Opioid Treatment (OBOT) with prescribed buprenorphine, and both outpatient and inpatient withdrawal management services for opioids, alcohol, and other substances. Furthermore, BayMark provides residential treatment services offering 24/7 support and, in select locations, mental health services. This multi-faceted approach allows BayMark to tailor treatment plans to the specific needs of each patient, guiding them through their recovery journey with a commitment to quality and accessibility.
United States only